Polypharmacy and multimorbidity are both currently rising. The number of medicines taken is the single biggest predictor of adverse drug events. Deprescribing is an approach to managing polypharmacy and reducing adverse outcomes. Multiple international evidence-based guidelines are emerging to promote discontinuation of high-risk medications, and use of alternative medical and non-pharmacological management. This review outlines the evidence base behind deprescribing, and suggests some pragmatic approaches to decision making around medication review.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12968/hmed.2019.0213 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!